
PDMP Advisory Committee The DC PDMP Advisory Committee is a multisector committee made up of 7 members. DC Health covers the licensing fees associated with the integration service for every health care entity in the District of Columbia that elects to connect its Electronic Health Record (EHR), Electronic Medical Record (EMR), Health Information Exchange (HIE), or Pharmacy Management System to the PDMP via Gateway integration. Gateway Integration The DC PDMP provides the option of PDMP-EHR integration to all health care facilities and practices in the District of Columbia, which allows health care practitioners to quickly and easily access DC PDMP data within their clinical workflow. NarxCare's analytics tools is an analytic clinical decision support tool that allows providers to assess overdose risk and monitor levels of stimulant, benzodiazepine, and opioid prescriptions. NarxCare The NarxCare feature of PMP AWARXE™ allows providers and dispensers to view patient health history and patient risk scores. PMP AWARXE™ is the web platform that providers can use to access the PDMP. To access the webinar recording, click here. Hear a DC Nurse Practitioner describe how PMP Gateway integration has affected patient care.

#PMP AWARE LOGIN HOW TO#
Learn how to access DC PDMP data/prescription history reports through your EHR utilizing Appriss Health's PMP Gateway Service.Safe Opioid Prescribing Pocket Guide This DIGITAL guide provides a number of resources to providers, including: CDC guidelines for safe opioid prescribing, a Morphine Milligram Equivalent (MME) conversion chart, a checklist for prescribing opioids for chronic pain, Medication Assisted Therapy (MAT) resources, and additional resources for providers and patients.ĭC PDMP EHR/EMR Integration Overview: Bamboo Health and the DC PDMP provide an informational webinar on implementing and utilizing EHR/EMR integration through PMP Gateway. Dispensers are required to report dispensations of gabapentin to the DC PDMP.
#PMP AWARE LOGIN FULL#
Read the notices to practitioners or FAQs about mandatory registration for full details.įor dispensers: As of June 7, 2019, gabapentin is a covered substance for the DC PDMP. MANDATORY PDMP REGISTRATION: All licensed prescribers and dispensers must register for the DC Prescription Drug Monitoring Program. To access the pre-recorded webinar, click here. Learn about the requirements of the Act as outlined above, how to perform a patient query, and other DC PDMP features.

MANDATORY PDMP QUERY WEBINAR RECORDING: The DC PDMP presents an informational webinar of the Prescription Drug Monitoring Program Query Amendment Act of 2020.

Prior to dispensing another refill after ninety days.Every ninety days thereafter while the course of treatment or therapy continues, or.Prior to prescribing or dispensing an opioid or benzodiazepine for more than seven consecutive days, and.The law requires prescribers and dispensers to query the PDMP: Prescription Drug Monitoring Program Query and Omnibus Health Amendments Act of 2020 became effective on March 16, 2021. MANDATORY PDMP QUERY: Mandatory query is now in effect in the District of Columbia. The PDMP also aims to enhance patient care by providing prescription monitoring information that will assure legitimate use of controlled substances in health care, including palliative care, research and other medical and pharmacological uses.

The Prescription Drug Monitoring Program (PDMP) aims to improve the District’s ability to identify and reduce diversion of prescription drugs in an efficient and cost effective manner that will not impede the appropriate medical utilization of controlled substances.
